Association between breast cancer and bone mineral density: The Dubbo Osteoporosis Epidemiology Study

Maturitas

Volumn 36, Issue 1, 2000, Pages 27-34

  Nguyen, T V ^a   Center, J R ^a   Eisman, J A ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BONE DENSITY; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENARCHE; OSTEOPOROSIS; OVULATION; RANDOMIZED CONTROLLED TRIAL;

AGED; BONE DENSITY; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DENSITOMETRY, X-RAY; FEMALE; HUMANS; LOGISTIC MODELS; NEW SOUTH WALES; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 0034738341     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00133-X     Document Type: Article

References (40)

1. Nguyen T.V., Jones G., Sambrook P.N., Kelly P.J., White C.P., Eisman J.A. The effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J. Clin. Endocrinol. Metab. 9:1995;2709-2714.
2. Kelsey J.L. Breast cancer epidemiology: summary and future direction. Epidemiol. Rev. 15:1993;256-263.
3. Tomiolo P.G., Levitz M., Zelenvich-Jacquotte A., Banerjee S., Koenig K., Shore R.E., Strax P., Pasternack B.S. A prospective study of endogenous estrogen and breast cancer in post-menopausal women. J. Natl. Cancer Inst. 87:1995;190-197.
4. Helzlsouer K.J., Alberg A.J., Bush T.L., Longcope C., Gordon G.B., Comstock G.W. A prospective study of endogenous hormones and breast cancer. Cancer Detect. Prev. 18:1994;79-85.
5. Wysowski D.K., Comstock G.W., Helsing K.N., Lau H.L. Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol. 125:1987;791-799.
6. Garland C.F., Friedlander N.J., Barrett-Connor E., Khaw K. Sex hormone and postmenopausal breast cancer: a prospective study in adult community. Am. J. Epidemiol. 135:1992;1220-1230.
7. Colditz G.A., Hankinson S.E., Hunter D.J., Willett W.C., Manson J.E., Stampfer M.J., Hennekens C., Rosner B., Speizer F.E. The use of estrogen and progestin and the risk of breast cancer in postmenopausal women. New Engl. J. Med. 332:1995;1589-1593.
8. Ewertz M. Influence of non-contraceptive exogenous and endogenous hormones on breast cancer risk in Denmark. Int. J. Cancer. 42:1988;832-838.
9. Bergkvist L., Adami H., Persson I., Hoover R., Shairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. New Engl. J. Med. 321:1989;293-297.
10. Kaufman D.W., Palmer J.R., de Mouzon J., Rosenberg L., Stolley P.D., Warshauer M.E., Zauber A.G., Shapiro S. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am. J. Epidemiol. 134:1991;1375-1385.
11. Wingo P.A., Layde P.M., Lee N.C., Rubin G., Ory H.W. The risk of breast cancer in postmenopausal women who have used replacement therapy. J. Am. Med. Assoc. 257:1987;209-215.
12. Olsson H., Hagglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am. J. Epidemiol. 136:1992;422-427.
13. Zhang Y., Kiel D.P., Kreger B.E., Cupples L.A., Ellison R.C., Dorgan J.F., Schatzkin A., Levy D., Felson D.T. Bone mass and the risk of breast cancer among postmenopausal women. New Engl. J. Med. 336:1997;611-617.
14. Cauley J.A., Lucas F.L., Kuller L.H., Vogt M.T., Browner W.S., Cummings S.R. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures. J. Am. Med. Assoc. 276:1996;1404-1408.
15. Nielsen H.E., Sasko P., Pilsen H.S., Godeberg C.C. Bone mineral content and estrogen receptors in women with breast tumors. Acta Radiol. 24:1985;247-251.
16. Atkins C.D. Bone mass and the risk of breast cancer. New Engl. J. Med. 336:1997;199. Letter.
17. Walker A.R.P., Burger H.M. Bone mass and the risk of breast cancer. New Engl. J. Med. 336:1997;199. Letter.
18. Bellesteros M., Nash D., Fix A., Bush T. Bone mass and the risk of breast cancer. New Engl. J. Med. 336:1997;200. Letter.
19. Shealy C.M. Bone mass and the risk of breast cancer (Letter). New Engl. J. Med. 336:1997;200.
20. Cauley J.A., Gutai J.P., Kuller L.H., Powell J.P. Reliability and interactions among sex hormones in postmenopausal women. Am. J. Epidemiol. 133:1991;50-57.
21. Nguyen T., Sambrook P., Kelly P., Jones G., Lord S., Freund J., Eisman J. Prediction of osteoporotic fractures by postural instability and bone density. Br. Med. J. 307:1993;1111-1115.
22. Nguyen T.V., Kelly P.J., Sambrook P.N., Gilbert C., Pocock N.A., Eisman J.A. Life-style factors and bone density in the elderly: implications for osteoporosis prevention. J. Bone Miner. Res. 9:1994;1339-1346.
23. Nguyen T.V., Sambrook P.N., Eisman J.A. Source of variability in bone density: implication for study design and analysis. J. Bone Miner. Res. 12:1997;124-135.
24. Breslow N.E., Day N.E. Statistical Methods in Cancer Research. I:1980;IARC, Lyon, France. IARC Sci. Publ. No. 32.
25. SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements. 1992;443-480 SAS Institute, Cary, NC. Release 6.07.
26. Bruzzi P., Green S.B., Byar D.P., Brinton L.A., Schairer C. Estimating the population attributable risk for multiple factors using case-control data. Am. J. Epidemiol. 122:1985;904-9114.
27. Cauley J.A., Seeley D.G., Ensrud K., Ettinger B., Black D., Cummings S.R. Estrogen replacement therapy and fractures in older women. Ann. Intern. Med. 122:1995;9-16.
28. Maxim P., Ettinger B., Spitalny G.M. Fracture protection provided by long-term estrogen treatment. Osteoporosis. Int. 5:1995;23-29.
29. Kiel D.P., Felson D.T., Anderson J.J., Wilson P.W.F., Moskowitz M.A. Hip fracture and the use of estrogens in postmenopausal women: The Framingham Study. New Engl. J. Med. 317:1987;1169-1174.
30. Dorgan J.F., Longscope C., Stephenson H.E., Falk R.T., Miller R., Franz C., Kahle L., Campbell W.S., Tangrea J.A., Schatzkin A. Relation of prodiagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol. Biomarkers. Prev. 5:1996;533-539.
31. Stanford J.L., Weiss N.S., Voigt L.F., Daling J.R., Habel L.A., Rossing M.A. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. J. Am. Med. Assoc. 274(2):1995;137-142.
32. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Am. J. Epidemiol. 13:1993;36-47.
33. Henderson B.E. The cancer question: an overview of recent epidemiological and retrospective data. Am. J. Obstet. Gynecol. 161:1989;1859-1864.
34. Schmid C. IGFs - function and clinical importance: the regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins. Ann. Intern. Med. 234:1993;535-542.
35. Murphy L.C. Antiestrogen action and growth factor regulation. Breast Cancer Res. Treat. 31:1994;61-71.
36. van Daele P.L., Stolk R.P., Burger H., Algra D., Grobbee D.E., Hofman A., Birkenhager J.C., Pols H.A. Bone density and non-insulin dependent diabetes mellitus. Ann. Intern. Med. 122:1995;409-414.
37. Eriksen E.F., Colvard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:1988;84-86.
38. Rossouw J.E., Finnegan L.P., Harlan W.R., Pinn V.W., Clifford C., McGowan J.A. The evolution of the Women's Health Initiative: perspectives from the NIH. J. Am. Med. Womens Assoc. 50(2):1995;50-55.
39. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet. 350:1997;1047-1059.
40. Naessen T., Persson I., Thor L., Mallmin H., Ljunghall S., Bergstrom R. Maintained bone density at advanced ages after long term treatment with low dose oestradiol implants. Br. J. Obstet. Gynaecol. 100(5):1993;454-459.